SCHEMBL4007137

SCHEMBL4007137

Cc1cc(C)cc(CN2C(=O)C(CC(C)C)N(C(=O)CN(C)C)C23CCNCC3)c1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5666390 0.83 ADRA2C (0.36) KMT2A
SCHEMBL1801253 0.72 CCR5 (0.36)
SCHEMBL12791101 0.57 KMT2A (0.76) KMT2A
SCHEMBL12791027 0.56 KMT2A (0.38) KMT2A
SCHEMBL12791190 0.56 KMT2A (0.34) KMT2A
SCHEMBL12790998 0.56 KMT2A (0.47) KMT2A
SCHEMBL18390390 0.55 CYP1A2 (0.38)
SCHEMBL3971878 0.53 CXCR4 (0.56) KMT2A
SCHEMBL8252575 0.52 ALDH1A1 (0.41) KMT2A
SCHEMBL25931529 0.52 CYP1A2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095402-A9 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2009-06-11 WO disclosed